Breaking News, Financial News

Abbott Laboratories

Nothing can stop Humira.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Abbott Laboratories 1Q 1Q Revenues: $7.7 billion (+15%) 1Q Earnings: $1.0 billion (-30%) Comments: Worldwide pharma sales were $4.1 billion (+13%, with 4% of that coming from currency rates). Domestic pharma sales grew 12% to $1.7 billion. Nutritional sales were up 12% to $1.3 billion, diagnostics sales grew 12% to $915 million, and vascular sales were up 16% to $747 million. Pharma sales were driven by Humira, which grew 36% to $1.4 billion, including a 7% bump from currency rates. 1Q0...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters